nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Rivastigmine—Alzheimer's disease	0.0756	0.432	CbGbCtD
Orlistat—CYP3A4—Donepezil—Alzheimer's disease	0.0605	0.345	CbGbCtD
Orlistat—CYP3A4—Galantamine—Alzheimer's disease	0.039	0.223	CbGbCtD
Orlistat—DAGLA—forebrain—Alzheimer's disease	0.0154	0.166	CbGeAlD
Orlistat—PLA2G4A—Tetrabenazine—Donepezil—Alzheimer's disease	0.0106	1	CbGdCrCtD
Orlistat—DAGLA—nervous system—Alzheimer's disease	0.00838	0.0899	CbGeAlD
Orlistat—DAGLA—central nervous system—Alzheimer's disease	0.00807	0.0865	CbGeAlD
Orlistat—DAGLA—cerebellum—Alzheimer's disease	0.00788	0.0846	CbGeAlD
Orlistat—FASN—telencephalon—Alzheimer's disease	0.00656	0.0704	CbGeAlD
Orlistat—DAGLA—brain—Alzheimer's disease	0.0064	0.0687	CbGeAlD
Orlistat—DAGLB—cerebellum—Alzheimer's disease	0.00611	0.0656	CbGeAlD
Orlistat—DAGLB—brain—Alzheimer's disease	0.00497	0.0533	CbGeAlD
Orlistat—ABHD16A—cerebellum—Alzheimer's disease	0.00463	0.0497	CbGeAlD
Orlistat—ABHD12—cerebellum—Alzheimer's disease	0.00434	0.0466	CbGeAlD
Orlistat—PLA2G7—brain—Alzheimer's disease	0.00401	0.043	CbGeAlD
Orlistat—FASN—cerebellum—Alzheimer's disease	0.00364	0.0391	CbGeAlD
Orlistat—ABHD12—brain—Alzheimer's disease	0.00353	0.0378	CbGeAlD
Orlistat—FASN—brain—Alzheimer's disease	0.00296	0.0318	CbGeAlD
Orlistat—PLA2G4A—nervous system—Alzheimer's disease	0.00186	0.02	CbGeAlD
Orlistat—PLA2G4A—central nervous system—Alzheimer's disease	0.00179	0.0192	CbGeAlD
Orlistat—PLA2G4A—brain—Alzheimer's disease	0.00142	0.0153	CbGeAlD
Orlistat—Influenza—Donepezil—Alzheimer's disease	0.00101	0.00235	CcSEcCtD
Orlistat—Pancreatitis—Donepezil—Alzheimer's disease	0.000987	0.00231	CcSEcCtD
Orlistat—Sweating increased—Donepezil—Alzheimer's disease	0.000981	0.00229	CcSEcCtD
Orlistat—Dry skin—Memantine—Alzheimer's disease	0.00097	0.00226	CcSEcCtD
Orlistat—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000965	0.00225	CcSEcCtD
Orlistat—Hypokalaemia—Memantine—Alzheimer's disease	0.000963	0.00225	CcSEcCtD
Orlistat—Dry skin—Rivastigmine—Alzheimer's disease	0.000949	0.00222	CcSEcCtD
Orlistat—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000945	0.00221	CcSEcCtD
Orlistat—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000942	0.0022	CcSEcCtD
Orlistat—Immune system disorder—Galantamine—Alzheimer's disease	0.000939	0.00219	CcSEcCtD
Orlistat—Gastritis—Memantine—Alzheimer's disease	0.000936	0.00219	CcSEcCtD
Orlistat—Breast disorder—Rivastigmine—Alzheimer's disease	0.000935	0.00218	CcSEcCtD
Orlistat—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000932	0.00218	CcSEcCtD
Orlistat—Gastritis—Rivastigmine—Alzheimer's disease	0.000916	0.00214	CcSEcCtD
Orlistat—Influenza—Memantine—Alzheimer's disease	0.000914	0.00214	CcSEcCtD
Orlistat—Asthma—Memantine—Alzheimer's disease	0.000914	0.00214	CcSEcCtD
Orlistat—Mental disorder—Galantamine—Alzheimer's disease	0.000911	0.00213	CcSEcCtD
Orlistat—Malnutrition—Galantamine—Alzheimer's disease	0.000905	0.00211	CcSEcCtD
Orlistat—Bronchospasm—Memantine—Alzheimer's disease	0.000899	0.0021	CcSEcCtD
Orlistat—Infestation NOS—Donepezil—Alzheimer's disease	0.000898	0.0021	CcSEcCtD
Orlistat—Infestation—Donepezil—Alzheimer's disease	0.000898	0.0021	CcSEcCtD
Orlistat—Pancreatitis—Memantine—Alzheimer's disease	0.000896	0.00209	CcSEcCtD
Orlistat—Depression—Donepezil—Alzheimer's disease	0.000895	0.00209	CcSEcCtD
Orlistat—Flatulence—Galantamine—Alzheimer's disease	0.000892	0.00208	CcSEcCtD
Orlistat—Sweating increased—Memantine—Alzheimer's disease	0.000891	0.00208	CcSEcCtD
Orlistat—Dysgeusia—Galantamine—Alzheimer's disease	0.000887	0.00207	CcSEcCtD
Orlistat—Renal failure—Donepezil—Alzheimer's disease	0.000883	0.00206	CcSEcCtD
Orlistat—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00088	0.00205	CcSEcCtD
Orlistat—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000877	0.00205	CcSEcCtD
Orlistat—Back pain—Galantamine—Alzheimer's disease	0.000876	0.00205	CcSEcCtD
Orlistat—Urinary tract infection—Donepezil—Alzheimer's disease	0.000873	0.00204	CcSEcCtD
Orlistat—Sweating increased—Rivastigmine—Alzheimer's disease	0.000871	0.00203	CcSEcCtD
Orlistat—Muscle spasms—Galantamine—Alzheimer's disease	0.00087	0.00203	CcSEcCtD
Orlistat—Vision blurred—Galantamine—Alzheimer's disease	0.000853	0.00199	CcSEcCtD
Orlistat—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00085	0.00198	CcSEcCtD
Orlistat—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00084	0.00196	CcSEcCtD
Orlistat—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000831	0.00194	CcSEcCtD
Orlistat—Malaise—Galantamine—Alzheimer's disease	0.000816	0.00191	CcSEcCtD
Orlistat—Infestation NOS—Memantine—Alzheimer's disease	0.000815	0.0019	CcSEcCtD
Orlistat—Infestation—Memantine—Alzheimer's disease	0.000815	0.0019	CcSEcCtD
Orlistat—Vertigo—Galantamine—Alzheimer's disease	0.000813	0.0019	CcSEcCtD
Orlistat—Depression—Memantine—Alzheimer's disease	0.000813	0.0019	CcSEcCtD
Orlistat—Haemoglobin—Donepezil—Alzheimer's disease	0.00081	0.00189	CcSEcCtD
Orlistat—Haemorrhage—Donepezil—Alzheimer's disease	0.000806	0.00188	CcSEcCtD
Orlistat—Hepatitis—Donepezil—Alzheimer's disease	0.000806	0.00188	CcSEcCtD
Orlistat—Renal failure—Memantine—Alzheimer's disease	0.000801	0.00187	CcSEcCtD
Orlistat—Palpitations—Galantamine—Alzheimer's disease	0.0008	0.00187	CcSEcCtD
Orlistat—Pharyngitis—Donepezil—Alzheimer's disease	0.0008	0.00187	CcSEcCtD
Orlistat—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000799	0.00187	CcSEcCtD
Orlistat—Infestation—Rivastigmine—Alzheimer's disease	0.000797	0.00186	CcSEcCtD
Orlistat—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000797	0.00186	CcSEcCtD
Orlistat—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000796	0.00186	CcSEcCtD
Orlistat—Depression—Rivastigmine—Alzheimer's disease	0.000795	0.00186	CcSEcCtD
Orlistat—Oedema peripheral—Donepezil—Alzheimer's disease	0.000794	0.00185	CcSEcCtD
Orlistat—Urinary tract infection—Memantine—Alzheimer's disease	0.000792	0.00185	CcSEcCtD
Orlistat—Urethral disorder—Donepezil—Alzheimer's disease	0.00079	0.00185	CcSEcCtD
Orlistat—Cough—Galantamine—Alzheimer's disease	0.00079	0.00184	CcSEcCtD
Orlistat—Convulsion—Galantamine—Alzheimer's disease	0.000784	0.00183	CcSEcCtD
Orlistat—Renal failure—Rivastigmine—Alzheimer's disease	0.000784	0.00183	CcSEcCtD
Orlistat—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000782	0.00183	CcSEcCtD
Orlistat—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000775	0.00181	CcSEcCtD
Orlistat—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000771	0.0018	CcSEcCtD
Orlistat—Chest pain—Galantamine—Alzheimer's disease	0.000771	0.0018	CcSEcCtD
Orlistat—Myalgia—Galantamine—Alzheimer's disease	0.000771	0.0018	CcSEcCtD
Orlistat—Anxiety—Galantamine—Alzheimer's disease	0.000768	0.00179	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000765	0.00179	CcSEcCtD
Orlistat—Sinusitis—Memantine—Alzheimer's disease	0.000765	0.00179	CcSEcCtD
Orlistat—Discomfort—Galantamine—Alzheimer's disease	0.000762	0.00178	CcSEcCtD
Orlistat—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000754	0.00176	CcSEcCtD
Orlistat—Dry mouth—Galantamine—Alzheimer's disease	0.000754	0.00176	CcSEcCtD
Orlistat—Sinusitis—Rivastigmine—Alzheimer's disease	0.000748	0.00175	CcSEcCtD
Orlistat—Haemoglobin—Memantine—Alzheimer's disease	0.000736	0.00172	CcSEcCtD
Orlistat—Haemorrhage—Memantine—Alzheimer's disease	0.000732	0.00171	CcSEcCtD
Orlistat—Hepatitis—Memantine—Alzheimer's disease	0.000732	0.00171	CcSEcCtD
Orlistat—Pharyngitis—Memantine—Alzheimer's disease	0.000726	0.0017	CcSEcCtD
Orlistat—Nervous system disorder—Galantamine—Alzheimer's disease	0.000725	0.00169	CcSEcCtD
Orlistat—Urinary tract disorder—Memantine—Alzheimer's disease	0.000723	0.00169	CcSEcCtD
Orlistat—Oedema peripheral—Memantine—Alzheimer's disease	0.000721	0.00168	CcSEcCtD
Orlistat—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00072	0.00168	CcSEcCtD
Orlistat—Skin disorder—Galantamine—Alzheimer's disease	0.000718	0.00168	CcSEcCtD
Orlistat—Urethral disorder—Memantine—Alzheimer's disease	0.000717	0.00168	CcSEcCtD
Orlistat—Hepatitis—Rivastigmine—Alzheimer's disease	0.000716	0.00167	CcSEcCtD
Orlistat—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000716	0.00167	CcSEcCtD
Orlistat—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000714	0.00167	CcSEcCtD
Orlistat—Alopecia—Donepezil—Alzheimer's disease	0.000712	0.00166	CcSEcCtD
Orlistat—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000711	0.00166	CcSEcCtD
Orlistat—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000707	0.00165	CcSEcCtD
Orlistat—Mental disorder—Donepezil—Alzheimer's disease	0.000706	0.00165	CcSEcCtD
Orlistat—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000705	0.00165	CcSEcCtD
Orlistat—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000702	0.00164	CcSEcCtD
Orlistat—Malnutrition—Donepezil—Alzheimer's disease	0.000702	0.00164	CcSEcCtD
Orlistat—Flatulence—Donepezil—Alzheimer's disease	0.000691	0.00161	CcSEcCtD
Orlistat—Dysgeusia—Donepezil—Alzheimer's disease	0.000687	0.0016	CcSEcCtD
Orlistat—Back pain—Donepezil—Alzheimer's disease	0.000679	0.00158	CcSEcCtD
Orlistat—Muscle spasms—Donepezil—Alzheimer's disease	0.000675	0.00158	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000673	0.00157	CcSEcCtD
Orlistat—Insomnia—Galantamine—Alzheimer's disease	0.000668	0.00156	CcSEcCtD
Orlistat—Paraesthesia—Galantamine—Alzheimer's disease	0.000663	0.00155	CcSEcCtD
Orlistat—Vision blurred—Donepezil—Alzheimer's disease	0.000661	0.00154	CcSEcCtD
Orlistat—Immune system disorder—Memantine—Alzheimer's disease	0.000661	0.00154	CcSEcCtD
Orlistat—Mediastinal disorder—Memantine—Alzheimer's disease	0.00066	0.00154	CcSEcCtD
Orlistat—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000651	0.00152	CcSEcCtD
Orlistat—Dyspepsia—Galantamine—Alzheimer's disease	0.00065	0.00152	CcSEcCtD
Orlistat—Alopecia—Memantine—Alzheimer's disease	0.000647	0.00151	CcSEcCtD
Orlistat—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000645	0.00151	CcSEcCtD
Orlistat—Decreased appetite—Galantamine—Alzheimer's disease	0.000642	0.0015	CcSEcCtD
Orlistat—Mental disorder—Memantine—Alzheimer's disease	0.000641	0.0015	CcSEcCtD
Orlistat—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000638	0.00149	CcSEcCtD
Orlistat—Malnutrition—Memantine—Alzheimer's disease	0.000637	0.00149	CcSEcCtD
Orlistat—Fatigue—Galantamine—Alzheimer's disease	0.000637	0.00149	CcSEcCtD
Orlistat—Malaise—Donepezil—Alzheimer's disease	0.000633	0.00148	CcSEcCtD
Orlistat—Alopecia—Rivastigmine—Alzheimer's disease	0.000633	0.00148	CcSEcCtD
Orlistat—Vertigo—Donepezil—Alzheimer's disease	0.00063	0.00147	CcSEcCtD
Orlistat—Flatulence—Memantine—Alzheimer's disease	0.000628	0.00147	CcSEcCtD
Orlistat—Mental disorder—Rivastigmine—Alzheimer's disease	0.000627	0.00146	CcSEcCtD
Orlistat—Dysgeusia—Memantine—Alzheimer's disease	0.000624	0.00146	CcSEcCtD
Orlistat—Malnutrition—Rivastigmine—Alzheimer's disease	0.000623	0.00146	CcSEcCtD
Orlistat—Back pain—Memantine—Alzheimer's disease	0.000616	0.00144	CcSEcCtD
Orlistat—Flatulence—Rivastigmine—Alzheimer's disease	0.000614	0.00143	CcSEcCtD
Orlistat—CYP3A4—nervous system—Alzheimer's disease	0.000614	0.00659	CbGeAlD
Orlistat—Cough—Donepezil—Alzheimer's disease	0.000612	0.00143	CcSEcCtD
Orlistat—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00061	0.00143	CcSEcCtD
Orlistat—Feeling abnormal—Galantamine—Alzheimer's disease	0.000609	0.00142	CcSEcCtD
Orlistat—Convulsion—Donepezil—Alzheimer's disease	0.000608	0.00142	CcSEcCtD
Orlistat—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000604	0.00141	CcSEcCtD
Orlistat—Back pain—Rivastigmine—Alzheimer's disease	0.000603	0.00141	CcSEcCtD
Orlistat—Vision blurred—Memantine—Alzheimer's disease	0.0006	0.0014	CcSEcCtD
Orlistat—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000599	0.0014	CcSEcCtD
Orlistat—Chest pain—Donepezil—Alzheimer's disease	0.000597	0.00139	CcSEcCtD
Orlistat—Myalgia—Donepezil—Alzheimer's disease	0.000597	0.00139	CcSEcCtD
Orlistat—Anxiety—Donepezil—Alzheimer's disease	0.000595	0.00139	CcSEcCtD
Orlistat—CYP3A4—central nervous system—Alzheimer's disease	0.000591	0.00634	CbGeAlD
Orlistat—Ill-defined disorder—Memantine—Alzheimer's disease	0.000591	0.00138	CcSEcCtD
Orlistat—Discomfort—Donepezil—Alzheimer's disease	0.00059	0.00138	CcSEcCtD
Orlistat—Vision blurred—Rivastigmine—Alzheimer's disease	0.000587	0.00137	CcSEcCtD
Orlistat—Dry mouth—Donepezil—Alzheimer's disease	0.000584	0.00136	CcSEcCtD
Orlistat—Abdominal pain—Galantamine—Alzheimer's disease	0.000584	0.00136	CcSEcCtD
Orlistat—Body temperature increased—Galantamine—Alzheimer's disease	0.000584	0.00136	CcSEcCtD
Orlistat—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000578	0.00135	CcSEcCtD
Orlistat—Malaise—Memantine—Alzheimer's disease	0.000574	0.00134	CcSEcCtD
Orlistat—Oedema—Donepezil—Alzheimer's disease	0.000573	0.00134	CcSEcCtD
Orlistat—Vertigo—Memantine—Alzheimer's disease	0.000572	0.00134	CcSEcCtD
Orlistat—Infection—Donepezil—Alzheimer's disease	0.000569	0.00133	CcSEcCtD
Orlistat—Palpitations—Memantine—Alzheimer's disease	0.000563	0.00131	CcSEcCtD
Orlistat—Malaise—Rivastigmine—Alzheimer's disease	0.000562	0.00131	CcSEcCtD
Orlistat—Nervous system disorder—Donepezil—Alzheimer's disease	0.000562	0.00131	CcSEcCtD
Orlistat—Vertigo—Rivastigmine—Alzheimer's disease	0.00056	0.00131	CcSEcCtD
Orlistat—Cough—Memantine—Alzheimer's disease	0.000556	0.0013	CcSEcCtD
Orlistat—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000554	0.00129	CcSEcCtD
Orlistat—Convulsion—Memantine—Alzheimer's disease	0.000552	0.00129	CcSEcCtD
Orlistat—Palpitations—Rivastigmine—Alzheimer's disease	0.000551	0.00129	CcSEcCtD
Orlistat—Hypersensitivity—Galantamine—Alzheimer's disease	0.000544	0.00127	CcSEcCtD
Orlistat—Cough—Rivastigmine—Alzheimer's disease	0.000544	0.00127	CcSEcCtD
Orlistat—Chest pain—Memantine—Alzheimer's disease	0.000542	0.00127	CcSEcCtD
Orlistat—Myalgia—Memantine—Alzheimer's disease	0.000542	0.00127	CcSEcCtD
Orlistat—Anxiety—Memantine—Alzheimer's disease	0.00054	0.00126	CcSEcCtD
Orlistat—Convulsion—Rivastigmine—Alzheimer's disease	0.00054	0.00126	CcSEcCtD
Orlistat—Discomfort—Memantine—Alzheimer's disease	0.000536	0.00125	CcSEcCtD
Orlistat—Myalgia—Rivastigmine—Alzheimer's disease	0.000531	0.00124	CcSEcCtD
Orlistat—Chest pain—Rivastigmine—Alzheimer's disease	0.000531	0.00124	CcSEcCtD
Orlistat—Dry mouth—Memantine—Alzheimer's disease	0.00053	0.00124	CcSEcCtD
Orlistat—Asthenia—Galantamine—Alzheimer's disease	0.00053	0.00124	CcSEcCtD
Orlistat—Anxiety—Rivastigmine—Alzheimer's disease	0.000529	0.00123	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000527	0.00123	CcSEcCtD
Orlistat—Discomfort—Rivastigmine—Alzheimer's disease	0.000524	0.00122	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000522	0.00122	CcSEcCtD
Orlistat—Oedema—Memantine—Alzheimer's disease	0.00052	0.00121	CcSEcCtD
Orlistat—Dry mouth—Rivastigmine—Alzheimer's disease	0.000519	0.00121	CcSEcCtD
Orlistat—Insomnia—Donepezil—Alzheimer's disease	0.000518	0.00121	CcSEcCtD
Orlistat—Infection—Memantine—Alzheimer's disease	0.000517	0.00121	CcSEcCtD
Orlistat—Paraesthesia—Donepezil—Alzheimer's disease	0.000514	0.0012	CcSEcCtD
Orlistat—Nervous system disorder—Memantine—Alzheimer's disease	0.00051	0.00119	CcSEcCtD
Orlistat—Oedema—Rivastigmine—Alzheimer's disease	0.000509	0.00119	CcSEcCtD
Orlistat—Diarrhoea—Galantamine—Alzheimer's disease	0.000506	0.00118	CcSEcCtD
Orlistat—Infection—Rivastigmine—Alzheimer's disease	0.000505	0.00118	CcSEcCtD
Orlistat—Skin disorder—Memantine—Alzheimer's disease	0.000505	0.00118	CcSEcCtD
Orlistat—Dyspepsia—Donepezil—Alzheimer's disease	0.000504	0.00118	CcSEcCtD
Orlistat—Hyperhidrosis—Memantine—Alzheimer's disease	0.000503	0.00117	CcSEcCtD
Orlistat—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000499	0.00116	CcSEcCtD
Orlistat—Decreased appetite—Donepezil—Alzheimer's disease	0.000498	0.00116	CcSEcCtD
Orlistat—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000494	0.00115	CcSEcCtD
Orlistat—Skin disorder—Rivastigmine—Alzheimer's disease	0.000494	0.00115	CcSEcCtD
Orlistat—Fatigue—Donepezil—Alzheimer's disease	0.000494	0.00115	CcSEcCtD
Orlistat—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000492	0.00115	CcSEcCtD
Orlistat—Pain—Donepezil—Alzheimer's disease	0.00049	0.00114	CcSEcCtD
Orlistat—Dizziness—Galantamine—Alzheimer's disease	0.000489	0.00114	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000474	0.00111	CcSEcCtD
Orlistat—Feeling abnormal—Donepezil—Alzheimer's disease	0.000472	0.0011	CcSEcCtD
Orlistat—Insomnia—Memantine—Alzheimer's disease	0.00047	0.0011	CcSEcCtD
Orlistat—Vomiting—Galantamine—Alzheimer's disease	0.00047	0.0011	CcSEcCtD
Orlistat—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000468	0.00109	CcSEcCtD
Orlistat—Paraesthesia—Memantine—Alzheimer's disease	0.000467	0.00109	CcSEcCtD
Orlistat—Rash—Galantamine—Alzheimer's disease	0.000466	0.00109	CcSEcCtD
Orlistat—Dermatitis—Galantamine—Alzheimer's disease	0.000465	0.00109	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000463	0.00108	CcSEcCtD
Orlistat—Headache—Galantamine—Alzheimer's disease	0.000463	0.00108	CcSEcCtD
Orlistat—Insomnia—Rivastigmine—Alzheimer's disease	0.00046	0.00107	CcSEcCtD
Orlistat—Dyspepsia—Memantine—Alzheimer's disease	0.000458	0.00107	CcSEcCtD
Orlistat—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000457	0.00107	CcSEcCtD
Orlistat—Urticaria—Donepezil—Alzheimer's disease	0.000455	0.00106	CcSEcCtD
Orlistat—Abdominal pain—Donepezil—Alzheimer's disease	0.000453	0.00106	CcSEcCtD
Orlistat—Body temperature increased—Donepezil—Alzheimer's disease	0.000453	0.00106	CcSEcCtD
Orlistat—Decreased appetite—Memantine—Alzheimer's disease	0.000452	0.00106	CcSEcCtD
Orlistat—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000449	0.00105	CcSEcCtD
Orlistat—Fatigue—Memantine—Alzheimer's disease	0.000448	0.00105	CcSEcCtD
Orlistat—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000448	0.00105	CcSEcCtD
Orlistat—Pain—Memantine—Alzheimer's disease	0.000445	0.00104	CcSEcCtD
Orlistat—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000442	0.00103	CcSEcCtD
Orlistat—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000439	0.00103	CcSEcCtD
Orlistat—Nausea—Galantamine—Alzheimer's disease	0.000439	0.00102	CcSEcCtD
Orlistat—Fatigue—Rivastigmine—Alzheimer's disease	0.000439	0.00102	CcSEcCtD
Orlistat—Pain—Rivastigmine—Alzheimer's disease	0.000435	0.00102	CcSEcCtD
Orlistat—Feeling abnormal—Memantine—Alzheimer's disease	0.000428	0.001	CcSEcCtD
Orlistat—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000425	0.000993	CcSEcCtD
Orlistat—Hypersensitivity—Donepezil—Alzheimer's disease	0.000422	0.000985	CcSEcCtD
Orlistat—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000419	0.000979	CcSEcCtD
Orlistat—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000416	0.000971	CcSEcCtD
Orlistat—Urticaria—Memantine—Alzheimer's disease	0.000413	0.000965	CcSEcCtD
Orlistat—Abdominal pain—Memantine—Alzheimer's disease	0.000411	0.00096	CcSEcCtD
Orlistat—Body temperature increased—Memantine—Alzheimer's disease	0.000411	0.00096	CcSEcCtD
Orlistat—Asthenia—Donepezil—Alzheimer's disease	0.000411	0.000959	CcSEcCtD
Orlistat—Pruritus—Donepezil—Alzheimer's disease	0.000405	0.000946	CcSEcCtD
Orlistat—Urticaria—Rivastigmine—Alzheimer's disease	0.000404	0.000944	CcSEcCtD
Orlistat—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000402	0.000939	CcSEcCtD
Orlistat—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000402	0.000939	CcSEcCtD
Orlistat—Diarrhoea—Donepezil—Alzheimer's disease	0.000392	0.000915	CcSEcCtD
Orlistat—Hypersensitivity—Memantine—Alzheimer's disease	0.000383	0.000895	CcSEcCtD
Orlistat—Dizziness—Donepezil—Alzheimer's disease	0.000379	0.000884	CcSEcCtD
Orlistat—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000375	0.000875	CcSEcCtD
Orlistat—Asthenia—Memantine—Alzheimer's disease	0.000373	0.000871	CcSEcCtD
Orlistat—Pruritus—Memantine—Alzheimer's disease	0.000368	0.000859	CcSEcCtD
Orlistat—Asthenia—Rivastigmine—Alzheimer's disease	0.000365	0.000852	CcSEcCtD
Orlistat—Vomiting—Donepezil—Alzheimer's disease	0.000364	0.00085	CcSEcCtD
Orlistat—Rash—Donepezil—Alzheimer's disease	0.000361	0.000843	CcSEcCtD
Orlistat—Dermatitis—Donepezil—Alzheimer's disease	0.000361	0.000842	CcSEcCtD
Orlistat—Pruritus—Rivastigmine—Alzheimer's disease	0.00036	0.00084	CcSEcCtD
Orlistat—Headache—Donepezil—Alzheimer's disease	0.000359	0.000838	CcSEcCtD
Orlistat—Diarrhoea—Memantine—Alzheimer's disease	0.000356	0.000831	CcSEcCtD
Orlistat—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000348	0.000813	CcSEcCtD
Orlistat—Dizziness—Memantine—Alzheimer's disease	0.000344	0.000803	CcSEcCtD
Orlistat—Nausea—Donepezil—Alzheimer's disease	0.00034	0.000794	CcSEcCtD
Orlistat—Dizziness—Rivastigmine—Alzheimer's disease	0.000336	0.000785	CcSEcCtD
Orlistat—Vomiting—Memantine—Alzheimer's disease	0.000331	0.000772	CcSEcCtD
Orlistat—Rash—Memantine—Alzheimer's disease	0.000328	0.000766	CcSEcCtD
Orlistat—Dermatitis—Memantine—Alzheimer's disease	0.000328	0.000765	CcSEcCtD
Orlistat—Headache—Memantine—Alzheimer's disease	0.000326	0.000761	CcSEcCtD
Orlistat—Vomiting—Rivastigmine—Alzheimer's disease	0.000323	0.000755	CcSEcCtD
Orlistat—Rash—Rivastigmine—Alzheimer's disease	0.000321	0.000749	CcSEcCtD
Orlistat—Dermatitis—Rivastigmine—Alzheimer's disease	0.00032	0.000748	CcSEcCtD
Orlistat—Headache—Rivastigmine—Alzheimer's disease	0.000319	0.000744	CcSEcCtD
Orlistat—Nausea—Memantine—Alzheimer's disease	0.000309	0.000721	CcSEcCtD
Orlistat—Nausea—Rivastigmine—Alzheimer's disease	0.000302	0.000706	CcSEcCtD
Orlistat—FASN—Disease—CCR5—Alzheimer's disease	6.31e-05	0.000216	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARGC1A—Alzheimer's disease	6.3e-05	0.000215	CbGpPWpGaD
Orlistat—FASN—Metabolism—HMOX1—Alzheimer's disease	6.28e-05	0.000214	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCR5—Alzheimer's disease	6.25e-05	0.000213	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PYY—Alzheimer's disease	6.2e-05	0.000212	CbGpPWpGaD
Orlistat—FASN—Disease—MTHFR—Alzheimer's disease	6.17e-05	0.000211	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—Alzheimer's disease	6.12e-05	0.000209	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS3—Alzheimer's disease	6.08e-05	0.000208	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	6.07e-05	0.000207	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	5.99e-05	0.000205	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GSK3B—Alzheimer's disease	5.94e-05	0.000203	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GSK3B—Alzheimer's disease	5.94e-05	0.000203	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARG—Alzheimer's disease	5.92e-05	0.000202	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PRKCG—Alzheimer's disease	5.91e-05	0.000202	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CREB1—Alzheimer's disease	5.9e-05	0.000201	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CREB1—Alzheimer's disease	5.9e-05	0.000201	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—INS—Alzheimer's disease	5.86e-05	0.0002	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—INS—Alzheimer's disease	5.86e-05	0.0002	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—INS—Alzheimer's disease	5.81e-05	0.000198	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL2—Alzheimer's disease	5.77e-05	0.000197	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL2—Alzheimer's disease	5.77e-05	0.000197	CbGpPWpGaD
Orlistat—FASN—Disease—CALM1—Alzheimer's disease	5.77e-05	0.000197	CbGpPWpGaD
Orlistat—FASN—Disease—APOE—Alzheimer's disease	5.75e-05	0.000196	CbGpPWpGaD
Orlistat—FASN—Metabolism—LPL—Alzheimer's disease	5.74e-05	0.000196	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPY—Alzheimer's disease	5.71e-05	0.000195	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CALM1—Alzheimer's disease	5.71e-05	0.000195	CbGpPWpGaD
Orlistat—FASN—Disease—CAV1—Alzheimer's disease	5.69e-05	0.000194	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LEP—Alzheimer's disease	5.69e-05	0.000194	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOE—Alzheimer's disease	5.69e-05	0.000194	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IAPP—Alzheimer's disease	5.68e-05	0.000194	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IGF1—Alzheimer's disease	5.67e-05	0.000194	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IGF1—Alzheimer's disease	5.67e-05	0.000194	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CAV1—Alzheimer's disease	5.63e-05	0.000192	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—Alzheimer's disease	5.56e-05	0.00019	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	5.53e-05	0.000189	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CRH—Alzheimer's disease	5.51e-05	0.000188	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	5.5e-05	0.000188	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ESR1—Alzheimer's disease	5.43e-05	0.000185	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDK5—Alzheimer's disease	5.37e-05	0.000183	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—F2—Alzheimer's disease	5.36e-05	0.000183	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—Alzheimer's disease	5.35e-05	0.000183	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	5.33e-05	0.000182	CbGpPWpGaD
Orlistat—FASN—Disease—NOTCH1—Alzheimer's disease	5.3e-05	0.000181	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOTCH1—Alzheimer's disease	5.25e-05	0.000179	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPS—Alzheimer's disease	5.23e-05	0.000178	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PPP3CA—Alzheimer's disease	5.2e-05	0.000177	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR6—Alzheimer's disease	5.17e-05	0.000177	CbGpPWpGaD
Orlistat—FASN—Metabolism—MTHFR—Alzheimer's disease	5.17e-05	0.000176	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PLAU—Alzheimer's disease	5.17e-05	0.000176	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOS3—Alzheimer's disease	5.14e-05	0.000175	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOS3—Alzheimer's disease	5.14e-05	0.000175	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	5.14e-05	0.000175	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CALM1—Alzheimer's disease	5.11e-05	0.000174	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NOS3—Alzheimer's disease	5.09e-05	0.000174	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TPI1—Alzheimer's disease	5.08e-05	0.000173	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CHAT—Alzheimer's disease	5.08e-05	0.000173	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	5.06e-05	0.000173	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CAV1—Alzheimer's disease	5.05e-05	0.000172	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—SST—Alzheimer's disease	4.99e-05	0.00017	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GAB2—Alzheimer's disease	4.99e-05	0.00017	CbGpPWpGaD
Orlistat—FASN—Disease—GSK3B—Alzheimer's disease	4.98e-05	0.00017	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.96e-05	0.000169	CbGpPWpGaD
Orlistat—FASN—Disease—CREB1—Alzheimer's disease	4.94e-05	0.000168	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GSK3B—Alzheimer's disease	4.92e-05	0.000168	CbGpPWpGaD
Orlistat—FASN—Disease—INS—Alzheimer's disease	4.91e-05	0.000168	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	4.89e-05	0.000167	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.89e-05	0.000167	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CREB1—Alzheimer's disease	4.88e-05	0.000167	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOB—Alzheimer's disease	4.87e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—APP—Alzheimer's disease	4.86e-05	0.000166	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—INS—Alzheimer's disease	4.86e-05	0.000166	CbGpPWpGaD
Orlistat—FASN—Metabolism—CALM1—Alzheimer's disease	4.83e-05	0.000165	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—Alzheimer's disease	4.81e-05	0.000164	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—F2—Alzheimer's disease	4.8e-05	0.000164	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL2—Alzheimer's disease	4.78e-05	0.000163	CbGpPWpGaD
Orlistat—FASN—Metabolism—CAV1—Alzheimer's disease	4.77e-05	0.000163	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—Alzheimer's disease	4.75e-05	0.000162	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IGF1—Alzheimer's disease	4.7e-05	0.00016	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PSENEN—Alzheimer's disease	4.7e-05	0.00016	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GAPDH—Alzheimer's disease	4.69e-05	0.00016	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—Alzheimer's disease	4.66e-05	0.000159	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.64e-05	0.000158	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APH1A—Alzheimer's disease	4.63e-05	0.000158	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.59e-05	0.000157	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PLCB1—Alzheimer's disease	4.58e-05	0.000156	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—A2M—Alzheimer's disease	4.53e-05	0.000155	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.53e-05	0.000155	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NCSTN—Alzheimer's disease	4.51e-05	0.000154	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AKT1—Alzheimer's disease	4.41e-05	0.00015	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AKT1—Alzheimer's disease	4.41e-05	0.00015	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LRP1—Alzheimer's disease	4.4e-05	0.00015	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CASP3—Alzheimer's disease	4.36e-05	0.000149	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CASP3—Alzheimer's disease	4.36e-05	0.000149	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—Alzheimer's disease	4.34e-05	0.000148	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—Alzheimer's disease	4.34e-05	0.000148	CbGpPWpGaD
Orlistat—FASN—Disease—NOS3—Alzheimer's disease	4.3e-05	0.000147	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GFAP—Alzheimer's disease	4.3e-05	0.000147	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GAL—Alzheimer's disease	4.3e-05	0.000147	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOS3—Alzheimer's disease	4.26e-05	0.000145	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IGF1—Alzheimer's disease	4.21e-05	0.000144	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—Alzheimer's disease	4.19e-05	0.000143	CbGpPWpGaD
Orlistat—FASN—Metabolism—INS—Alzheimer's disease	4.11e-05	0.00014	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.04e-05	0.000138	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—Alzheimer's disease	4.02e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAPK8—Alzheimer's disease	4.01e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAPK8—Alzheimer's disease	4.01e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AKT1—Alzheimer's disease	4e-05	0.000137	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AKT1—Alzheimer's disease	4e-05	0.000137	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ACHE—Alzheimer's disease	3.94e-05	0.000134	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—Alzheimer's disease	3.94e-05	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—INPP5D—Alzheimer's disease	3.89e-05	0.000133	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.82e-05	0.000131	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS3—Alzheimer's disease	3.82e-05	0.00013	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—A2M—Alzheimer's disease	3.79e-05	0.000129	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—Alzheimer's disease	3.7e-05	0.000126	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—Alzheimer's disease	3.7e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS1—Alzheimer's disease	3.69e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ENO1—Alzheimer's disease	3.69e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PSEN2—Alzheimer's disease	3.67e-05	0.000125	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP2D6—Alzheimer's disease	3.62e-05	0.000124	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CASP3—Alzheimer's disease	3.62e-05	0.000123	CbGpPWpGaD
Orlistat—FASN—Metabolism—NOS3—Alzheimer's disease	3.6e-05	0.000123	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—BCHE—Alzheimer's disease	3.43e-05	0.000117	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	3.4e-05	0.000116	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—Alzheimer's disease	3.4e-05	0.000116	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—Alzheimer's disease	3.4e-05	0.000116	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PRKCG—Alzheimer's disease	3.39e-05	0.000116	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPY—Alzheimer's disease	3.38e-05	0.000115	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IAPP—Alzheimer's disease	3.35e-05	0.000115	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK8—Alzheimer's disease	3.32e-05	0.000113	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—Alzheimer's disease	3.3e-05	0.000113	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CRH—Alzheimer's disease	3.26e-05	0.000111	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PLCB1—Alzheimer's disease	3.24e-05	0.000111	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCR5—Alzheimer's disease	3.21e-05	0.00011	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.18e-05	0.000108	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—Alzheimer's disease	3.14e-05	0.000107	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCA1—Alzheimer's disease	3.14e-05	0.000107	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPS—Alzheimer's disease	3.09e-05	0.000105	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PPP3CA—Alzheimer's disease	3.07e-05	0.000105	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—Alzheimer's disease	3.07e-05	0.000105	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—Alzheimer's disease	3.03e-05	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTK2B—Alzheimer's disease	3.03e-05	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GAB2—Alzheimer's disease	2.94e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK2—Alzheimer's disease	2.94e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SST—Alzheimer's disease	2.94e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CALM1—Alzheimer's disease	2.93e-05	0.0001	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GSK3A—Alzheimer's disease	2.92e-05	9.96e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APP—Alzheimer's disease	2.87e-05	9.8e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.87e-05	9.78e-05	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—Alzheimer's disease	2.85e-05	9.72e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—Alzheimer's disease	2.82e-05	9.62e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—Alzheimer's disease	2.8e-05	9.55e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—Alzheimer's disease	2.8e-05	9.55e-05	CbGpPWpGaD
Orlistat—PNLIP—Disease—AKT1—Alzheimer's disease	2.8e-05	9.55e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—F2—Alzheimer's disease	2.76e-05	9.41e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—Alzheimer's disease	2.75e-05	9.38e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PLCB1—Alzheimer's disease	2.71e-05	9.24e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARGC1A—Alzheimer's disease	2.71e-05	9.24e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HMOX1—Alzheimer's disease	2.69e-05	9.19e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—Alzheimer's disease	2.56e-05	8.74e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—Alzheimer's disease	2.56e-05	8.74e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NGFR—Alzheimer's disease	2.53e-05	8.62e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—Alzheimer's disease	2.52e-05	8.61e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CREB1—Alzheimer's disease	2.51e-05	8.57e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADAM10—Alzheimer's disease	2.47e-05	8.42e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LPL—Alzheimer's disease	2.46e-05	8.41e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL2—Alzheimer's disease	2.46e-05	8.39e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.44e-05	8.32e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AKT1—Alzheimer's disease	2.36e-05	8.07e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AKT1—Alzheimer's disease	2.36e-05	8.07e-05	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AKT1—Alzheimer's disease	2.34e-05	7.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—S100B—Alzheimer's disease	2.33e-05	7.97e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—Alzheimer's disease	2.32e-05	7.92e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.29e-05	7.82e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF2—Alzheimer's disease	2.22e-05	7.58e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—Alzheimer's disease	2.22e-05	7.57e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.17e-05	7.41e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF1R—Alzheimer's disease	2.15e-05	7.33e-05	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—Alzheimer's disease	2.14e-05	7.32e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—Alzheimer's disease	2.12e-05	7.25e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—Alzheimer's disease	2.08e-05	7.09e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CALM1—Alzheimer's disease	2.07e-05	7.07e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.07e-05	7.07e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—Alzheimer's disease	2.06e-05	7.05e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LPL—Alzheimer's disease	2.06e-05	7.03e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CAV1—Alzheimer's disease	2.05e-05	6.98e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MEF2C—Alzheimer's disease	2.04e-05	6.97e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRKCG—Alzheimer's disease	2e-05	6.84e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.99e-05	6.78e-05	CbGpPWpGaD
Orlistat—FASN—Disease—AKT1—Alzheimer's disease	1.98e-05	6.75e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AKT1—Alzheimer's disease	1.96e-05	6.68e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NGF—Alzheimer's disease	1.95e-05	6.66e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.91e-05	6.53e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCR5—Alzheimer's disease	1.9e-05	6.48e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—Alzheimer's disease	1.86e-05	6.34e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.85e-05	6.3e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—Alzheimer's disease	1.8e-05	6.14e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—INS—Alzheimer's disease	1.76e-05	6.02e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—AKT1—Alzheimer's disease	1.75e-05	5.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CALM1—Alzheimer's disease	1.73e-05	5.91e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LEP—Alzheimer's disease	1.73e-05	5.89e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—Alzheimer's disease	1.73e-05	5.89e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-05	5.84e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKT1—Alzheimer's disease	1.66e-05	5.66e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ESR1—Alzheimer's disease	1.65e-05	5.63e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—F2—Alzheimer's disease	1.63e-05	5.56e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.59e-05	5.44e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—Alzheimer's disease	1.55e-05	5.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GSK3B—Alzheimer's disease	1.5e-05	5.1e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CREB1—Alzheimer's disease	1.48e-05	5.06e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—INS—Alzheimer's disease	1.47e-05	5.03e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-05	4.95e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF1—Alzheimer's disease	1.43e-05	4.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—Alzheimer's disease	1.41e-05	4.83e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-05	4.42e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.19e-05	4.06e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.19e-05	4.06e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.14e-05	3.89e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.1e-05	3.75e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-05	3.75e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—Alzheimer's disease	1.09e-05	3.72e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.06e-05	3.62e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-05	3.45e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AKT1—Alzheimer's disease	1.01e-05	3.44e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—Alzheimer's disease	9.32e-06	3.18e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.23e-06	3.15e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.12e-06	3.11e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.65e-06	2.95e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.65e-06	2.95e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—Alzheimer's disease	8.55e-06	2.92e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.48e-06	2.89e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.04e-06	2.74e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.58e-06	2.59e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.35e-06	2.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKT1—Alzheimer's disease	7.11e-06	2.43e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—Alzheimer's disease	7.04e-06	2.4e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—Alzheimer's disease	6.44e-06	2.2e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.34e-06	2.16e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.31e-06	2.15e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKT1—Alzheimer's disease	5.95e-06	2.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.77e-06	1.97e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.19e-06	1.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.85e-06	1.66e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.84e-06	1.65e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.79e-06	1.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.21e-06	1.44e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—INS—Alzheimer's disease	4.13e-06	1.41e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.62e-06	1.24e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.31e-06	1.13e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.67e-06	5.68e-06	CbGpPWpGaD
